Cancer-related breakthrough pain

British Journal of Hospital Medicine

Volumn 67, Issue 8, 2006, Pages 414-416

  Davies, Andrew N ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33747263299     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2006.67.8.21960     Document Type: Conference Paper

References (26)

1. Benitez del Rosaria MA, Martin AS, Ortega JJ, Feria M (2001) Temporary sedation with midazolam for control of severe incident pain. J Pain Symptom Manage 21(5): 439-42
2. Christie JM, Simmonds M, Patt R et al (1998) Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol 10: 3238-45
3. Coluzzi PH, Schwartzberg L, Conroy JD et al (2001) Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulphate immediate release (MSIR®). Pain 91: 123-30
4. Davies AN, O'Donnell V (1997) Trigeminal neuralgia managed by a change in lifestyle. J Palliat Care 13(2): 50-1
5. Enting RH, Mucchiano C, Oldenmenger WH et al (2005) The "pain pen" for breakthrough cancer pain: a promising treatment. J Pain Symptom Manage 29(2): 213-17
6. Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E (1998) Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 90(8): 611-16
7. Fortner BV, Okon TA, Portenoy RK (2002) A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 3(1): 38-44
8. Gardner-Nix J (2001) Oral transmucosal fentanyl and sufentanil for incident pain. J Pain Symptom Manage 22(2): 627-30
9. Hanks G (2001) Oral transmucosal fentanyl citrate for the management of breakthrough pain. Eur J Palliat Care 8(1): 6-9
10. Hanks GW, De Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5): 587-93
11. Hanks GW, Nugent M, Higgs CM, Busch MA (2004) Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use study. Palliat Med 18(8): 698-704
12. Mercadante S, Radbruch L, Caraceni A et al (2002) Episodic (breakthrough) pain. Consensus conference of an Expert Working Group of the European Association for Palliative Care. Cancer 94: 832-9
13. Mercadante S, Villari P, Ferrera P, Casuccio A (2004a) Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage 28(5): 505-10
14. Mercadante S, Villari P, Ferrera P, Bianchi M, Casuccio A (2004b) Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage 27(4): 352-9
15. Parlow JL, Milne B, Tod DA, Stewart GI, Griffiths JM, Dudgeon DJ (2005) Self-administered nitrous oxide for the management of incident pain in terminally ill patients: a blinded case series. Palliat Med 19: 3-8
16. Pavis H, Wilcock A, Edgecombe J et al (2002) Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer. J Pain Symptom Manage 24(6): 598-602
17. Portenoy RK, Hagen NA (1990) Breakthrough pain: definition, prevalence and characteristics. Pain 41: 273-81
18. Portenoy RK, Payne R, Coluzzi P et al (1999) Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 79: 303-12
19. Portenoy RK, Forbes K, Lussier D, Hanks G (2004) Difficult pain problems: an integrated approach. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine. 3rd edn. Oxford University Press, Oxford: 438-58
20. Simmonds MA (1999) Management of breakthrough pain due to cancer. Oncology (Huntingt) 13: 1103-8
21. Sloman R, Brown P, Aldana E, Chee E (1994) The use of relaxation for the promotion of comfort and pain relief in persons with advanced cancer. Contemp Nurse 3: 6-12
22. Twycross R, Wilcock A, Thorp S (1998) Palliative Care Formulary. Radcliffe Medical Press, Abingdon
23. Twycross RG (1978) Relief of pain. In: Saunders CM, ed. The Management of Terminal Disease. Edward Arnold (Publishers) Ltd, London
24. World Health Organization (1996) Cancer Pain Relief. 2nd edn. WHO, Geneva
25. Zeppetella G, O'Doherty CA, Collins S (2000) Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage 20(2): 87-92
26. Zeppetella G (2000) Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain. Palliat Med 14: 57-8